| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 29, 2005
Accepted on July 29, 2005
Endocrinology Section, Medical Service, Veterans Affairs Medical Center, Birmingham, AL; Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL; Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL
* To whom correspondence should be addressed. E-mail: sjfrank{at}uab.edu.
The abundance of surface GHR is an important determinant of cellular GH sensitivity and is regulated at both transcriptional and post-transcriptional levels. In previous studies of GHR-expressing JAK2-deficient human fibrosarcoma cells (
2A-GHR), we demonstrated that stable transfection with JAK2 resulted in increased steady-state levels of mature GHR (endoH-resistant; Mr 115-140 kD) relative to precursor GHR (endoH-sensitive; Mr 100 kD). We now examine further the effects of JAK2 on GHR trafficking by comparing
2A-GHR to
2A-GHR cells stably reconstituted with JAK2 (C14 cells). In the presence of JAK2, GHR surface expression was increased, as assessed by surface biotinylation, 125I-hGH cell surface binding, and immunofluorescence microscopy assays. While the absence of JAK2 precluded GH-stimulated signaling, GH-induced GHR disulfide linkage (a proxy for the GH-induced conformational changes in the GHR dimer) proceeded independent of JAK2 expression, indicating that the earliest steps in GH-induced GHR triggering are not prevented by the absence of JAK2. RNA interference-mediated knockdown of JAK2 in C14 cells resulted in a decreased mature:precursor ratio, supporting a primary role for JAK2 either in enhancing GHR biogenesis or dampening mature GHR degradation. To address these potential mechanisms, metabolic pulse-chase labeling experiments and experiments in which the fate of previously synthesized GHR was followed by anti-GHR immunoblotting after cycloheximide treatment ("cycloheximide chase" experiments) were performed. These indicated that the presence of JAK2 conferred modest enhancement (1.3-1.5-fold) in GHR maturation, but substantially prolonged the t1/2 of the mature GHR, suggesting a predominant effect on mature GHR stability. Cycloheximide chase experiments with metalloprotease, proteasome, and lysosome inhibitors indicated that the enhanced stability of mature GHR conferred by JAK2 is not related to effects on constitutive receptor metalloproteolysis, but rather is due to reduced constitutive endosomal/lysosomal degradation of the mature GHR. These results are discussed in the context of emerging information on how JAK-family members modulate surface expression of other cytokine receptors.
This article has been cited by other articles:
![]() |
K. G. S. Kumar, B. Varghese, A. Banerjee, D. P. Baker, S. N. Constantinescu, S. Pellegrini, and S. Y. Fuchs Basal Ubiquitin-independent Internalization of Interferon {alpha} Receptor Is Prevented by Tyk2-mediated Masking of a Linear Endocytic Motif J. Biol. Chem., July 4, 2008; 283(27): 18566 - 18572. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Asa, R. DiGiovanni, J. Jiang, M. L. Ward, K. Loesch, S. Yamada, T. Sano, K. Yoshimoto, S. J. Frank, and S. Ezzat A Growth Hormone Receptor Mutation Impairs Growth Hormone Autofeedback Signaling in Pituitary Tumors Cancer Res., August 1, 2007; 67(15): 7505 - 7511. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nilsson, G. Bjursell, and M. Kannius-Janson Nuclear Jak2 and Transcription Factor NF1-C2: a Novel Mechanism of Prolactin Signaling in Mammary Epithelial Cells Mol. Cell. Biol., August 1, 2006; 26(15): 5663 - 5674. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Radtke, A. Jorissen, H. S.-V. de Leur, P. C. Heinrich, and I. Behrmann Three Dileucine-like Motifs within the Interbox1/2 Region of the Human Oncostatin M Receptor Prevent Efficient Surface Expression in the Absence of an Associated Janus Kinase J. Biol. Chem., February 17, 2006; 281(7): 4024 - 4034. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |